Reindl, Caroline
Walther, Katrin
Allgäuer, Anna-Lena
Lang, Johannes D.
Welte, Tamara M.
Stritzelberger, Jenny
Gollwitzer, Stephanie
Schwarz, Michael
Trollmann, Regina
Madzar, Dominik
Knott, Michael
Doerfler, Arnd
Seifert, Frank
Rössler, Karl
Brandner, Sebastian
Rampp, Stefan
Schwab, Stefan
Hamer, Hajo M.
Funding for this research was provided by:
Universitätsklinikum Erlangen
Article History
Received: 13 May 2023
Accepted: 16 August 2023
First Online: 1 September 2023
Competing interests
: Disclosure of Conflicts of Interest HM Hamer has served on the scientific advisory board of Angelini, Corlieve, Eisai, GW/Jazz, Sandoz, UCB Pharma, UNEEG and UCB/Zogenix. He served on the speakers’ bureau of or received unrestricted grants from Ad-Tech, Alnylam, Angelini, Bracco, Desitin, Eisai, GW, Micromed, Nihon Kohden, Novartis, Pfizer, and UCB Pharma. JDL served on the speakers’ bureau of and received travel grants from Eisai and UCB Pharma. FS received speaker honoraria from Teva, Lilly and Novartis. RT received speaker honoraria from PCT Pharma, Desitin, Eisai, Roche, UCB.